Papers
12
Total Citations
338
H-Index
8
About
Ted A. Skolarus is a leading urologic oncologist and health services researcher whose work critically examines the intersection of surgical technology, healthcare policy, and patient outcomes. His research focuses on the diffusion of advanced treatment technologies—particularly robotic surgery and intensity-modulated radiotherapy—in prostate cancer care, and the implications of their use for both overtreatment and healthcare spending. Skolarus has made major contributions by demonstrating that advanced technologies are often disseminated to low-risk patients who may not benefit from them, as shown in his highly cited 2013 *JAMA* paper (141 citations). He also investigates the real-world consequences of technology adoption, including readmission rates after robotic vs. open cystectomy and the impact of state certificate-of-need laws on surgical volume. His work on unnecessary care, notably the 2020 piece “Too Much Surgery,” highlights the tens of billions of dollars wasted annually on avoidable procedures. With over 330 citations across his top papers, Skolarus is a key voice in evidence-based urologic oncology, advocating for smarter, more equitable use of surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1
- 2Does Robotic Technology Mitigate the Challenges of Large Prostate Size?50 citations · 2010
- 3
- 4Robotic surgery in urologic oncology: gathering the evidence28 citations · 2010
- 5Too Much Surgery25 citations · 2020
- 6
- 7
- 8Technology Diffusion and Diagnostic Testing for Prostate Cancer13 citations · 2013
- 9Technology Diffusion and Prostate Cancer Quality of Care5 citations · 2014
- 10Understanding Early Functional Recovery After Robotic Prostatectomy4 citations · 2011